Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer
Open Access
- 30 April 2023
- journal article
- research article
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 69 (4) , 179-187
Abstract
The expression of six transmembrane epithelial antigen of the prostate (STEAP2) is increased in prostate cancer when compared to normal tissue, suggesting a role for STEAP2 in disease progression. This study aimed to determine whether targeting STEAP2 with an anti-STEAP2 polyclonal antibody (pAb) or CRISPR/Cas9 knockout influenced aggressive prostate cancer traits. Gene expression analysis of the STEAP gene family was performed in a panel of prostate cancer cell lines; C4-2B, DU145, LNCaP and PC3. The highest increases in STEAP2 gene expression were observed in C4-2B and LNCaP cells (pSTEAP2 from C4-2B and LNCaP cells and viability, proliferation, migration and invasion assessed. When exposed to an anti-STEAP2 pAb, cell viability significantly decreased (pSTEAP2 was knocked out, cell viability and proliferation was significantly decreased when compared to wild-type cells (pSTEAP2 has a functional role in driving aggressive prostate cancer traits and could provide a novel therapeutic target for the treatment of prostate cancer.Keywords
This publication has 37 references indexed in Scilit:
- Prostate cancer screening with prostate-specific antigen: A guide to the guidelinesProstate International, 2016
- STAMPing at the crossroads of normal physiology and disease statesMolecular and Cellular Endocrinology, 2016
- A role for STEAP2 in prostate cancer progressionClinical & Experimental Metastasis, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Early Detection of Prostate Cancer: AUA GuidelineJournal of Urology, 2013
- Induction of reactive oxygen species generation inhibits epithelial–mesenchymal transition and promotes growth arrest in prostate cancer cellsMolecular Carcinogenesis, 2013
- A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell DeathMolecular Cell, 2012
- Targeting tumor cell motility to prevent metastasisAdvanced Drug Delivery Reviews, 2011
- Monoclonal antibody to six transmembrane epithelial antigen of prostate-4 influences insulin sensitivity by attenuating phosphorylation of P13K (P85) and Akt: Possible mitochondrial mechanismJournal of Bioenergetics and Biomembranes, 2011
- Targeting the extrinsic apoptosis signaling pathway for cancer therapyCancer Immunology, Immunotherapy, 2011